Microenvironment-Based Diabetic Foot Ulcer Nanomedicine.
Huang F, Lu X, Yang Y, Yang Y, Li Y, Kuai L, Li B, Dong H, Shi J. · 2023
Read Microenvironment-Based Diabetic Foot Ulcer Nanomedicine. by Huang F, Lu X, Yang Y, Yang Y, Li Y, Kuai L, Li B, Dong H, Shi J. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9839871.txt.
Introduction
Huang and co-authors review nanomedicine for diabetic foot ulcers, built around the wound microenvironment. These ulcers are among the gravest results of diabetes. They are chronic wounds that refuse to close. Nerve damage, vessel disease, and infection all drive them.
The ulcer setting is harsh in several ways at once. High sugar, low oxygen, and stubborn infection combine. Inflammation runs hot and proteases run high there. Current clinical care leaves many patients unhealed. About a fifth to a third of diabetics face such ulcers. Roughly 40% return within a year of healing. The review maps the normal stages of wound closure. It then sorts nano sized treatments by the flaw they target. Sugar lowering, infection control, and vessel growth all appear. Matrix rebuilding and skin regrowth strategies close the set. The authors weigh the field's gaps and next steps.
Catalog record
| CREATOR | Huang F, Lu X, Yang Y, Yang Y, Li Y, Kuai L, Li B, Dong H, Shi J. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Microenvironment‐Based Diabetic Foot Ulcer Nanomedicine By Fang Huang, Xiangyu Lu, Yan Yang, Yushan Yang, Yongyong Li, Le Kuai, Bin Li, Haiqing Dong, Jianlin Shi Published in: Advanced Science DOI: 10.1002/advs.202203308 ABSTRACT Abstract Diabetic foot ulcers (DFU), one of the most serious complications of diabetes, are essentially chronic, nonhealing wounds caused by diabetic neuropathy, vascular disease, and bacterial infection. Given its pathogenesis, the DFU microenvironment is rather complicated and characterized by hyperglycemia, ischemia, hypoxia, hyperinflammation, and persistent infection. However, the current clinical therapies for DFU are dissatisfactory, which drives researchers to turn attention to advanced nanotechnology to address DFU therapeutic bottlenecks. In the last decade, a large number of multifunctional nanosystems based on the microenvironment of DFU have been developed with positive effects in DFU therapy, forming a novel concept of “DFU nanomedicine”. However, a systematic overview of DFU nanomedicine is still unavailable in the literature. This review summarizes the microenvironmental characteristics of DFU, presents the main progress of wound healing, and summaries the state‐of‐the‐art therapeutic strategies for DFU. Furthermore, the main challenges and future perspectives in this field are discussed and prospected, aiming to fuel and foster the development of DFU nanomedicines successfully. Keywords: diabetic foot ulcers, microenvironment, nanomedicine, therapeutic strategy, wound healing INTRODUCTION Diabetic foot ulcers (DFU) have imposed severe health and economic burden globally. Approximately 19%–34% of diabetics are influenced by DFU and up to one‐third of all diabetes care costs are estimated to be for lower‐limb‐related problems (about $5.9 billion annually in the United States).[ 1 ] The recurrence rate within one year is ≈40% after successful healing, making DFU treatment extremely challenging.[ 2 ] It is generally accepted that persistent hyperglycemia caused diabetic neuropathy and vasculopathy are the main aetiologies of DFU, and further bacterial infection exacerbates the difficulty of treating DFU.[ 3 ] In brief, hyperglycemia upregulates the expression of proinflammatory factors, causing oxidative stress on nerve cells and neuropathy (mainly nerve damage in the foot).[ 4 ] Specifically, motor neuropathy may lead to muscle deformity and atrophy, and autonomic neuropathy is prone to cause skin dehiscence. Worse still, lesions of widespread sensory nerves in the skin of diabetics reduce or lose basic “sensation” and “pain,” resulting in the insensitivity or even unconscious of the nervous system to the wound and consequently greatly increased risk of ulcers and even amputation.[ 3 , 5 ] In addition, hyperglycemia causes glycation of hemoglobin, narrowing of blood vessels, and alteration of the erythrocyte membrane, leading to inadequate oxygen supply and vasculopathy to the wound tissue.[ 6 ] Vasculopathy may also cause or intensify the loss of “sensation” in patients. On these bases, combined bacterial infections and biofilm formation further complicate the wound microenvironment. Finally, the various predisposing factors discussed above prevent diabetic wounds from undergoing four stages of normal wound healing: hemostasis, inflammation, proliferation, and remodeling. Instead, the wound may stagnate in the long‐term inflammatory phase, leading to the formation of nonhealing chronic wounds, i.e., DFU.[ 7 ] For more details on cellular and molecular events involved in DFU, one can refer to comprehensive reviews.[ 6 , 8 ] Complicated pathogenesis of DFU results in a complex microenvironment, such as hyperglycemia, ischemia, hypoxia, hyperinflammation, persistent infection, high protease activity,[ 9 ] inadequate energy supply,[ 10 ] local necrotic tissue,[ 11 ] and wide range variation of pH (7.0–8.9) in chronic phase.[ 12 ] Based on the characteristics of DFU, the standard clinical treatment includes surgical debridement, pressure off‐loading, antibiotic therapy, and wound dressing.[ 13 ] Unfortunately, long‐term and repeated debridement will bring extreme pain and economic burdens to the patients. Furthermore, the emergence of drug‐resistant microorganisms may invalidate the effect of antibiotics; meanwhile, conventional dressings are monofunctional and necessitate frequent changes.[ 14 ] Therefore, adjuvant therapies such as gene/growth factor therapy and stem cell therapy have gradually attracted clinical attention. In particular, stem cells are crucial for the wound healing process. As a pivotal “seed cell,” stem cells recruit macrophages and endothelial lineage cells to ischemic and damaged tissue, secrete growth factors and establish a favorable environment for wound repair.[ 15 ] Nevertheless, several issues regarding effective delivery remain, such as 1) the short half‐life of therapeutic genes/growth factors; 2) the highly complicated DFU microenvironment with extensive proteases; and 3) the short survival time of stem cells in DFU microenvironment results in disoptimal retention in precise positions.[ 15 , 16 ] Fortunately, nanotechnology possesses advantages such as drug delivery and controlled release that can address the above issues efficiently. More encouragingly, except for the role of “deliverers,” a number of nanomaterials also act as “healers” in the treatment of DFU, in which the nanomaterials themselves are capable of treating diseases directly. Over the past decade, novel strategies based on nanosystems for remodeling the DFU microenvironment have been rapidly developed (Figure 1 ), forming a concept of “DFU nanomedicine,” i.e., developing nanosystems for DFU therapy. Nanotechnology‐based DFU therapies are well documented and summarized by focusing on the types of nanocarriers and drugs.[ 17 ] Herein, the microenvironment‐guided design motifs for nanomedicine, which, however, is of great significance in developing nanosystems for greatly enhanced effectiveness in DFU clinical treatment, will be covered. In this review, the main processes of wound healing, the microenvironment of DFU, and nanotechnology‐based strategies to remodel DFU's microenvironment will be summarized to provide constructive ideas and implications for developing more effective DFU nanomedicines. [Figure: Timeline of progress in “diabetic foot ulcer (DFU) nanomedicine”.[ 18 ]] MAIN PROCESSES OF WOUND HEALING Unsurprisingly, the skin is susceptible to damage from various external/internal factors. Once the wound occurs, the typical external appearance is bleeding, accompanied by microbial infection which is not beneficial for health. Thus, effective wound healing is of critical importance, and it generally contains following four continuous and overlapping events. Hemostasis 2.1. Hemostasis is the first response of the body to a wound. Immediately after injury, blood vessels constrict to reduce bleeding; subsequently, platelets accumulate in the wound and activate, forming the platelet plug, a process known as primary hemostasis.[ 19 ] Activated platelets also secrete cytokines such as platelet‐derived growth factor (PDGF), transforming growth factor‐β (TGF‐β), and epidermal growth factor (EGF) to recruit inflammatory cells and promote the proliferation and migration of fibroblasts and keratinocytes. Next, to enable platelet plug clotting and strengthening, the classical endogenous and exogenous coagulation pathways are initiated, stimulating the formation of fibrin, which in turn forms fibrin chains in the wound. Then, under the action of Factor XIII, the fibrin chains interconnect, establishing a dense fibrin network that eventually forms a thrombus at the wound. The thrombus serves as a temporary substrate for wound healing, provides a scaffold for cell migration, and protects the wound from pathogenic invasion.[ 8 , 20 ] Inflammation 2.2. The hallmark of the onset of the inflammatory phase is the recruitment of inflammatory cells, which overlaps with the hemostatic phase.[ 21 ] The recruitment of inflammatory cells is associated with the release of various “danger signals” at the wound site, such as pathogen‐associated molecular patterns (PAMPs) and danger‐associated molecular patterns (DMEMs).[ 8 , 22 ] Neutrophils are the “first responders” to the signal,[ 23 ] followed by monocytes, macrophages, lymphocytes, and others that arrive at the site of injury. In acute wounds, neutrophils fight against microorganisms